tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Lewis, 140 are a BUY (53.03%), 119 are a HOLD (45.08%), 5 are a SELL (1.89%).
Analyst David Lewis, carries an average stock price target met ratio of 83.77% that have a potential upside of 19.24% achieved within 308 days. Previously, David Lewis worked at MORGAN STANLEY.
David Lewis’s has documented 453 price targets and ratings displayed on 25 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on ABT, Abbott Laboratories at 15-Jul-2025.
Analyst best performing recommendations are on SWAV (SHOCKWAVE MEDICAL).
The best stock recommendation documented was for ABMD (ABIOMED) at 2/11/2020. The price target of $165 was fulfilled within 2 days with a profit of $10.82 (6.15%) receiving and performance score of 30.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 02-Nov-2022
$388
$6.98 (1.83%)
$355
3 years 4 months 1 days ago
(02-Nov-2022)
2/5 (40%)
$14.49 (3.88%)
88
Hold Since 02-Nov-2022
$380
$-1.02 (-0.27%)
$235
3 years 4 months 1 days ago
(02-Nov-2022)
1/2 (50%)
$6.49 (1.74%)
36
Hold Since 01-Nov-2022
$380
$-1.02 (-0.27%)
$350
3 years 4 months 2 days ago
(01-Nov-2022)
24/41 (58.54%)
$2.18 (0.58%)
138
Buy Since 30-Jun-2021
$300
$-81.02 (-21.26%)
$425
3 years 4 months 19 days ago
(12-Oct-2022)
1/2 (50%)
$57.23 (23.57%)
20
Sell Since 11-Feb-2020
$235
$-146.02 (-38.32%)
$275
3 years 7 months 16 days ago
(15-Jul-2022)
6/8 (75%)
$-33.23 (-12.39%)
143
What Year was the first public recommendation made by David Lewis?
